Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting transcription factors in cancer — from undruggable to reality
John H. Bushweller
Nature reviews. Cancer (2019) Vol. 19, Iss. 11, pp. 611-624
Open Access | Times Cited: 721

Showing 1-25 of 721 citing articles:

Liquid–liquid phase separation in human health and diseases
Bin Wang, Lei Zhang, Tong Dai, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 439
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Xin Li, Yongcheng Song
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 328
Advances in targeting ‘undruggable’ transcription factors with small molecules
Matthew J. Henley, Angela N. Koehler
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 9, pp. 669-688
Closed Access | Times Cited: 258
Therapeutic strategies targeting FOXO transcription factors
Giampaolo Calissi, Eric W.‐F. Lam, Wolfgang Link
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 1, pp. 21-38
Closed Access | Times Cited: 247
Novel therapeutic strategies: targeting epithelial–mesenchymal transition in colorectal cancer
Nan Zhang, Aik Seng Ng, Shijie Cai, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 8, pp. e358-e368
Open Access | Times Cited: 242
Artificial intelligence in cancer target identification and drug discovery
Yujie You, Xin Lai, Yi Pan, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 215
TF-PROTACs Enable Targeted Degradation of Transcription Factors
Jing Liu, He Chen, H. Ümit Kanıskan, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 23, pp. 8902-8910
Open Access | Times Cited: 176
Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation
Michael J. Bond, Craig M. Crews
RSC Chemical Biology (2021) Vol. 2, Iss. 3, pp. 725-742
Open Access | Times Cited: 161
Recent Developments in PROTAC‐Mediated Protein Degradation: From Bench to Clinic
Zhenyi Hu, Craig M. Crews
ChemBioChem (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 158
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 154
An overview of PROTACs: a promising drug discovery paradigm
Liu Zi, Mingxing Hu, Yang Yu, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 153
Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS–mitochondrial fission–mitophagy axis
Ming Liu, Yumei Fan, Danyu Li, et al.
Molecular Oncology (2021) Vol. 15, Iss. 8, pp. 2084-2105
Open Access | Times Cited: 126
Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy
Jing Gao, Bo Hou, Qiwen Zhu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 116
Epithelial cells activate fibroblasts to promote esophageal cancer development
Yamei Chen, Shihao Zhu, Tianyuan Liu, et al.
Cancer Cell (2023) Vol. 41, Iss. 5, pp. 903-918.e8
Open Access | Times Cited: 89
Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
Zhen Zeng, Minyang Fu, Yuan Hu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 58
The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity
Alastair Davies, Amina Zoubeidi, Himisha Beltran, et al.
Cancer Discovery (2023) Vol. 13, Iss. 8, pp. 1771-1788
Closed Access | Times Cited: 50
Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity
Brian Ortmann
BMJ Oncology (2024) Vol. 3, Iss. 1, pp. e000154-e000154
Open Access | Times Cited: 23
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability
Mariko Takahashi, Harrison B. Chong, Siwen Zhang, et al.
Cell (2024) Vol. 187, Iss. 10, pp. 2536-2556.e30
Open Access | Times Cited: 21
Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2
Hao Yang, Zhong‐Yi Li, Shiqi Zhu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18
Current and Future Treatment Strategies for Rhabdomyosarcoma
Celine Chen, Heathcliff Dorado García, Monika Scheer, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 136
Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens
Abhishek Maiti, Caitlin R. Rausch, Jorge E. Cortés, et al.
Haematologica (2020) Vol. 106, Iss. 3, pp. 894-898
Open Access | Times Cited: 115
Transcription Factors in Cancer Development and Therapy
Kanchan Vishnoi, Navin Viswakarma, Ajay Rana, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2296-2296
Open Access | Times Cited: 114
Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function
Lingyue Gao, Zhuo‐Xun Wu, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2021) Vol. 57, pp. 100770-100770
Closed Access | Times Cited: 96
Small Protein Hidden in lncRNA LOC90024 Promotes “Cancerous” RNA Splicing and Tumorigenesis
Nan Meng, Min Chen, De Chen, et al.
Advanced Science (2020) Vol. 7, Iss. 10
Open Access | Times Cited: 93
Transcription Factor Inhibition: Lessons Learned and Emerging Targets
Andrew Chen, Angela N. Koehler
Trends in Molecular Medicine (2020) Vol. 26, Iss. 5, pp. 508-518
Open Access | Times Cited: 91
Page 1 - Next Page

Scroll to top